Short answer
CVS Health (CVS) filed its Q1 2026 10-Q quarterly report on May 6, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $100.4B (up 6.2% year over year) with net income of $2.9B.
Q1 2026 key financials · XBRL
- Revenue
- $100.4B
- +6.2% YoY
- Net income
- $2.9B
- +65.4% YoY
- Operating margin
- 4.7%
- EPS (diluted)
- $2.30
- +63.1% YoY
Source: XBRL data from the CVS Health (CVS) Q1 2026 10-Q on SEC EDGAR. USD.
CVS Health Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Forward-looking disclosures only; quarterly revenue and YoY change not provided
- Profitability metrics and actual margin percentages not provided
- Segment or product-line performance numbers not provided
- Cash position, operating cash flow, and capital deployment figures not provided
- Outlook limited to risk disclosures; actual results may differ materially due to uncertainties
Risk Factors
- No risk factors provided; excerpt covers stock repurchases only
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CVS Health quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.